Anna Henningham
Anna Henningham
כתובת אימייל מאומתת בדומיין uq.edu.au
כותרת
צוטט על ידי
צוטט על ידי
שנה
Disease manifestations and pathogenic mechanisms of group A Streptococcus
MJ Walker, TC Barnett, JD McArthur, JN Cole, CM Gillen, A Henningham, ...
Clinical microbiology reviews 27 (2), 264-301, 2014
5772014
DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection
MJ Walker, A Hollands, ML Sanderson-Smith, JN Cole, JK Kirk, ...
Nature medicine 13 (8), 981-985, 2007
3872007
A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development
M Sanderson-Smith, DMP De Oliveira, J Guglielmini, DJ McMillan, T Vu, ...
The Journal of infectious diseases 210 (8), 1325-1338, 2014
2282014
The Classical Lancefield Antigen of Group A Streptococcus Is a Virulence Determinant with Implications for Vaccine Design
NM van Sorge, JN Cole, K Kuipers, A Henningham, RK Aziz, ...
Cell host & microbe 15 (6), 729-740, 2014
842014
Streptococcal toxins: role in pathogenesis and disease
TC Barnett, JN Cole, T Rivera‐Hernandez, A Henningham, JC Paton, ...
Cellular microbiology 17 (12), 1721-1741, 2015
642015
Pathogenesis of group A streptococcal infections
A Henningham, TC Barnett, PG Maamary, MJ Walker
Discovery medicine 13 (72), 329-342, 2012
612012
Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone
PG Maamary, NLB Zakour, JN Cole, A Hollands, RK Aziz, TC Barnett, ...
The FASEB Journal 26 (11), 4675-4684, 2012
582012
Human pathogenic streptococcal proteomics and vaccine development
JN Cole, A Henningham, CM Gillen, V Ramachandran, MJ Walker
Proteomics-Clinical Applications 2 (3), 387-410, 2008
522008
Conserved anchorless surface proteins as group A streptococcal vaccine candidates
A Henningham, E Chiarot, CM Gillen, JN Cole, M Rohde, M Fulde, ...
Journal of molecular medicine 90 (10), 1197-1207, 2012
502012
Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation
I Secundino, A Lizcano, KM Roupé, X Wang, JN Cole, J Olson, SR Ali, ...
Journal of Molecular Medicine 94 (2), 219-233, 2016
492016
Role of group A Streptococcus HtrA in the maturation of SpeB protease
JN Cole, JA Aquilina, PG Hains, A Henningham, KS Sriprakash, ...
Proteomics 7 (24), 4488-4498, 2007
492007
RESEARCH ARTICLE Role of group A Streptococcus HtrA in the maturation of SpeB protease
JN Cole, JA Aquilina, PG Hains, A Henningham, KS Sriprakash, ...
49*2007
Mechanisms of group A Streptococcus resistance to reactive oxygen species
A Henningham, S Döhrmann, V Nizet, JN Cole
FEMS microbiology reviews 39 (4), 488-508, 2015
482015
Group A streptococcal vaccine candidates: potential for the development of a human vaccine
A Henningham, CM Gillen, MJ Walker
Host-Pathogen Interactions in Streptococcal Diseases, 207-242, 2012
472012
Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein
MJ Bauer, MM Georgousakis, T Vu, A Henningham, A Hofmann, M Rettel, ...
Vaccine 30 (12), 2197-2205, 2012
382012
Mutual exclusivity of hyaluronan and hyaluronidase in invasive group A Streptococcus
A Henningham, M Yamaguchi, RK Aziz, K Kuipers, CZ Buffalo, S Dahesh, ...
Journal of Biological Chemistry 289 (46), 32303-32315, 2014
312014
Differing efficacies of lead group A Streptococcal vaccine candidates and full-length m protein in cutaneous and invasive disease models
T Rivera-Hernandez, M Pandey, A Henningham, J Cole, B Choudhury, ...
MBio 7 (3), e00618-16, 2016
282016
An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development system
PM Moyle, J Hartas, A Henningham, MR Batzloff, MF Good, I Toth
Nanomedicine: Nanotechnology, Biology and Medicine 9 (7), 935-944, 2013
282013
Coiled-coil destabilizing residues in the group A Streptococcus M1 protein are required for functional interaction
CM Stewart, CZ Buffalo, JA Valderrama, A Henningham, JN Cole, V Nizet, ...
Proceedings of the National Academy of Sciences 113 (34), 9515-9520, 2016
262016
Structure-informed design of an enzymatically inactive vaccine component for group A Streptococcus
A Henningham, DJ Ericsson, K Langer, LW Casey, B Jovcevski, ...
MBio 4 (4), e00509-13, 2013
222013
המערכת אינה יכולה לבצע את הפעולה כעת. נסה שוב מאוחר יותר.
מאמרים 1–20